Associated Papers
LKB1 mutations are not associated with the efficacy of first-line and second-line chemotherapy in patients with advanced non-small-cell lung cancer (NSCLC): a post hoc analysis of the TAILOR trial.
Vernieri C et al.
Esmo Open, 2020
32467099 (PubMed )
Supplement: esmoopen-2020-000748supp001.pdf
Select a paper to view details